Barry S. Skikne
Directeur/Membre du Conseil chez TVAX BIOM
Profil
Barry S.
Skikne is an Independent Director at TVAX Biomedical, Inc. He previously worked as the Director-Bone Marrow Transplantation Program at the University of Kansas from 1993 to 2007.
Dr. Skikne completed his undergraduate degree at the University of the Witwatersrand and holds a doctorate degree from the University of South Africa.
Postes actifs de Barry S. Skikne
| Sociétés | Poste | Début |
|---|---|---|
| TVAX BIOM | Directeur/Membre du Conseil | 01/12/2011 |
Anciens postes connus de Barry S. Skikne
| Sociétés | Poste | Fin |
|---|---|---|
| University of Kansas | Corporate Officer/Principal | 01/07/2007 |
Formation de Barry S. Skikne
| University of the Witwatersrand | Undergraduate Degree |
| University of South Africa | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
TVAX Biomedical, Inc.
 TVAX Biomedical, Inc. BiotechnologyHealth Technology TVAX Biomedical, Inc. manufactures and sells healthcare products. It is a biotechnology company, which focuses on the development of targeted cell-based immunotherapies for the treatment of cancer and is performing clinical trials with specific focus on brain cancers. The firm’s proprietary immunologic treatment, TVAX Immunotherapy, uses a patient's cells to create activated, genetically unique cancer-killing T cells that can destroy the patient's cancer cells, including cancer stem cells, which are widely believed to be responsible for cancer growth, spread and metastasis. The company was founded by Gray W. Wood, Frank P. Holladay, Catherine E. Lucasey and Lowell Lynn Tilzer on July 14, 2011 and is headquartered in Lenexa, KS. | Health Technology |
